 |
 |

 ION CHANNEL
and RECEPTOR LIGANDS
TOXINS & ALKALOIDS

Evaluation
of 8 Alkaloids for Activity at Neuronal Alpha BUNGAROTOXIN SITES |
| |
|
| |
|
| |
Dr. S. Wonnacott, School of Biology and Biochemistry, University
of Bath, UK
|
| |
Neuronal nicotinic acetylcholine receptors (nAChR) are heterogeneous
with respect to subunit composition, brain distribution and pharmacology.
Alpha Bungarotoxin is selective for a subtype of neuronal nAChR that
probably incorporates the Alpha7 subunit.
This neuronal nAChR is distinct from muscle nAChR, although the
latter also binds Alpha Bungarotoxin with high affinity. However, muscle and
brain Alpha Bungarotoxin-sensitive nAChR can be discriminated by the natural
product Methyllycaconitine (MLA). MLA has nanomolar affinity at the brain sites,
compared with micromolar affinity at muscle nAChR and at Alpha Bungarotoxin-insensitive
neuronal nAChR [Ward et al., FEBS Lett. 270:45 (1990)]. Because
several natural products marketed by LATOXAN have some structural similarities
with MLA, it is of interest to ascertain if they have activity at MLA-sensitive
neuronal nAChR, defined by specific [125I] Alpha Bungarotoxin binding
to brain membranes.
The compounds were made up in ethanol and serial dilutions in buffer were assayed
for competition for [125I] Alpha Bungarotoxin binding to rat brain
membranes,
as previously described [MacAllan et al., FEBS Lett. 226:357 (1988)].
Each drug was assayed at least twice. IC50 values were determined
by linear regression of Hill plots.
|
| |
Results : IC50 values at brain [125I] Alpha Bungarotoxin
binding sites. |
| |
|
| |
|
| |
Nudikauline is exceptionally potent: 200 times more potent than the
next most active compound, Karakoline. Nudikauline is comparable to Methyllycaconitine
in terms of its IC50 and the two compounds are closely related
structurally.
The other Nicotinic compounds all lack the phenylsuccinamide sidechain and have
only modest [125I] Alpha Bungarotoxin binding activity.
Of the three Na+ channel blockers N-Desactyllappaconitine has significant
nicotinic activity, with an IC50 of 4.7 µM. Lappaconitine and Deltaline
are 17 and 28 times less potent, and an IC50>10-4 M
is not considered to be specific. |
| |
|
| |
|
| |
Latoxan
- 20, Rue Léon Blum - F-26000 VALENCE - France
Phone: +33.4.75.41.91.91 - Fax: +33.4.41.91.99
contact@latoxan.com
For
Research Purposes Only - Not for Human Use.
|
|